Carmot Therapeutics: Funding, Investors & Team (Sep 2026)
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, Chemotype Evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies. Carmot Therapeutics is headquartered in San Francisco, California and was founded in 2008.
Carmot Therapeutics has raised $150M across 1 funding round on record, the most recent a Series E of $150M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Carmot Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2023.
Carmot Therapeutics Funding Rounds
Carmot Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Carmot Therapeutics Funding Compared to Other Biotechnology Startups
Carmot Therapeutics' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Carmot Therapeutics in Biotechnology and Berkeley
Companies Similar to Carmot Therapeutics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Carmot Therapeutics Funding FAQs
What does Carmot Therapeutics do?
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, Chemotype Evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies. Carmot Therapeutics is headquartered in San Francisco, California and was founded in 2008.
How much funding has Carmot Therapeutics raised?
Carmot Therapeutics has raised $150M across 1 round on record. The most recent is a Series E of $150M announced in May 2023.
When did Carmot Therapeutics last raise funding?
Carmot Therapeutics' most recent funding round on record is a Series E of $150M, announced in May 2023.
Who is the CEO of Carmot Therapeutics?
Stig K Hansen is listed as CEO at Carmot Therapeutics.
Where is Carmot Therapeutics headquartered?
Carmot Therapeutics is based in Berkeley, California, United States.
How many employees does Carmot Therapeutics have?
Carmot Therapeutics is in the 11-50 employee band.
How does Carmot Therapeutics' funding compare to other Biotechnology startups?
Carmot Therapeutics' latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Carmot Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Carmot Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.